Thomas Edward Hamilton - 30 Jun 2021 Form 4 Insider Report for Larimar Therapeutics, Inc. (LRMR)

Role
Director
Signature
/s/ Jennifer Johansson, Attorney-in-fact
Issuer symbol
LRMR
Transactions as of
30 Jun 2021
Net transactions value
+$496,212
Form type
4
Filing time
02 Jul 2021, 16:08:42 UTC
Previous filing
21 May 2021
Next filing
12 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRMR Common Stock Purchase $496,212 +56,710 +43% $8.75 190,130 30 Jun 2021 Direct
holding LRMR Common Stock 159,433 30 Jun 2021 FA Life Sciences, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.